Publications

Optimising Methods for Collecting Participant-Reported Safety Endpoints in Antimalarial Drug Clinical Research.

Allen, E; CHANDLER, CI; Mehta, U; Mandimika, N; Pace, C; Bames, KI;

2015

Drug safety, (2015).38 10

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.

HARDING-ESCH, E; Jofre-Bonet, M; Dhanjal, JK; Burr, S; EDWARDS, T; HOLLAND, M; Sillah, A; West, S; Lietman, T; Keenan, J; MABEY, D; BAILEY, R;

2015

PLoS neglected tropical diseases, (2015).9 4 10.1371/journal.pntd.0003670.

Corrigendum to 'Characterisation of a mobilisable plasmid conferring florfenicol and chloramphenicol resistance in Actinobacillus pleuropneumoniae' [Veterinary Microbiology 178 (2015) 279–282].

Bossé, JT; Li, Y; Atherton, TG; Walker, S; Williamson, SM; Rogers, J; Chaudhuri, RR; Weinert, LA; Holden, MT G; Maskell, DJ; Tucker, AW; WREN, BW; Rycroft, AN; Langford, PR;

2015

Veterinary microbiology, (2015).179 3-4 10.1016/j.vetmic.2015.07.002.

Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.

LALANI, M; KAUR, H; Mohammed, N; Mailk, N; Wyk, AV; Jan, S; Kakar, RM; Mojadidi, MK; LESLIE, T;

2015

The American journal of tropical medicine and hygiene, (2015).92 6 Supp 10.4269/ajtmh.14-0394.

Directional gene flow and ecological separation in Yersinia enterocolitica.

Reuter, S; Corander, J; De Been, M; Harris, S; Cheng, L; Hall, M; THOMSON, NR; McNally, A;

2015

Microbial genomics, (2015).1 3 10.1099/mgen.0.000030.

Chemical and bioassay techniques to authenticate quality of the anti-leishmanial drug miltefosine.

KAUR, H; SEIFERT, K; Hawkes, GE; Coumbarides, GS; Alvar, J; CROFT, SL;

2015

The American journal of tropical medicine and hygiene, (2015).92 6 Supp 10.4269/ajtmh.14-0586.

The Murray collection of pre-antibiotic era Enterobacteriacae: a unique research resource.

Baker, KS; Burnett, E; McGregor, H; Deheer-Graham, A; Boinett, C; Langridge, GC; Wailan, AM; Cain, AK; THOMSON, NR; Russell, JE; Parkhill, J;

2015

Genome medicine, (2015).7 1 10.1186/s13073-015-0222-7.

Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia.

YEUNG, S; Lawford, HL S; Tabernero, P; Nguon, C; Van Wyk, A; Malik, N; DeSousa, M; Rada, O; Boravann, M; Dwivedi, P; Hostetler, DM; Swamidoss, I; Green, MD; Fernandez, FM; KAUR, H;

2015

The American journal of tropical medicine and hygiene, (2015).92 6 Supp 10.4269/ajtmh.14-0391.

The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

KNIGHT, GM; Colijn, C; Shrestha, S; Fofana, M; Cobelens, F; WHITE, RG; Dowdy, DW; Cohen, T;

2015

Clinical infectious diseases, (2015).61Supp Suppl 10.1093/cid/civ579.

Distributional Considerations in Economic Responses to Antimicrobial Resistance.

Coast, J; SMITH, RD;

2015

Public health ethics, (2015).8 3 10.1093/phe/phv004.